Maximizing the use of scarce resources: vial optimization.
Somerville
M
M
Brooksby
A
A
Scott
D G I
DG
D000911:Antibodies, Monoclonal / Q000191:economics*; D018501:Antirheumatic Agents / Q000191:economics*; D003363:Cost Control / Q000379:methods; D016527:Drug Costs / Q000706:statistics & numerical data; D004739:England; D006295:Health Resources; D006801:Humans; D000069285:Infliximab; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab